Bayer has settled a class action lawsuit regarding claims that Monsanto’s weedkiller Roundup caused non-Hodgkin’s lymphoma. The settlement includes the lawsuits from the federal multidistrict litigation and state of California. The deal includes an estimated range of $8.8-$9.6 billion for current lawsuits and an additional $1.25 billion to provide relief for potential future plaintiffs who may develop an illness but are not current plaintiffs.
In addition to the Roundup settlement, Bayer also reached a settlement of $400 million in the dicamba drift cases and approximately $820 million in some of the PCB contamination lawsuits brought by public entities.
Bayer purchased Monsanto in 2018.
On May 25, a federal court in Missouri approved a $21.5 million settlement between Monsanto and a class of consumers who alleged the agrochemical giant used misleading labeling on its Roundup weed killer. The complaint stated that Monsanto misled consumers about how much Roundup could be made from bottles of concentrate. The concentrate labels say the formula “makes up to” a certain amount of herbicide when mixed with water, but the instructions’ fine print says the formula should be mixed at much higher concentrations for best results. 
Glyphosate, the active ingredient in Monsanto’s Roundup® herbicide, was reported to be “the most important causal factor” in the worldwide increase of gluten intolerance and celiac disease, according to a paper written by MIT scientist Stephanie Seneff and Dr. Anthony Samsel and published by the Journal of Interdisciplinary Toxicology.
While the reaction from trading partners was immediate with a significant impact on markets and Monsanto opponents did not miss an opportunity to crow, USDA says genetically modified wheat plants found in Oregon was an isolated event.
STOLL BERNE is investigating claims that Northwest wheat farmers may have as a result of the discovery of genetically modified wheat that may have contaminated a wheat farm in Eastern Oregon.